Phase 1 Cohort Expansion of Flotetuzumab, a CD123×CD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)Geoffrey L. Uy, John F. DiPersio, John E. Godwin et al.|Blood|2018Cited by 40
Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”Paolo A. Ascierto, Antonio Maria Grimaldi, Nicolas Acquavella et al.|Journal of Translational Medicine|2013Cited by 18